PFKFB3 and diabetic kidney disease: Next, we investigated whether inhibiting glycolysis leads to a decrease in DKD development, and 3PO, a specific small-molecule inhibitor of PFKFB3, was administered to db/db mice intraperitoneally (Fig. 7A–C).